ESIC Stops Ondansetron Batch After Quality Test Failure

The Employees’ State Insurance Corporation (ESIC) has flagged a batch of Ondansetron Oral Solution 2 mg/5 ml as “Not of Standard Quality (NSQ)”, following a lab report from the Central Drugs Laboratory (CDL), Kolkata. The batch has failed to meet Indian Pharmacopoeia (IP) standards, specifically in the test for “Related Substances”. Details of the NSQ […]